Publications by authors named "Olof Borga"

Claim this Profile
P
Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients.
Olof Borgå, Elsa Lilienberg, Helena Bjermo, Fredrik Hansson, Nina Heldring

Adv Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study.
Olof Borgå, Roger Henriksson, Helena Bjermo, Elsa Lilienberg, Nina Heldring

Adv Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiating mucosal and hepatic metabolism of budesonide by local pretreatment with increasing doses of ketoconazole in the proximal jejunum.
Janeric Seidegård, Lars Nyberg, Olof Borgå

Eur J Pharm Sci· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole.
Janeric Seidegård, Lars Nyberg, Olof Borgå

Eur J Pharm Sci· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of NXY-059, a nitrone-based free radical trapping agent, in healthy young and elderly subjects.
Charlotte Edenius, Stig Strid, Olof Borgå, Anna Breitholtz-Emanuelsson, Kerstin Lanbeck Vallén

J Stroke Cerebrovasc Dis· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study of organic acid transporter mediated pharmacokinetic interaction between NXY-059 and cefuroxime.
Matts Kågedal, Dag Nilsson, Gunilla Huledal, Ingalill Reinholdsson, Yi-Fang Cheng

J Clin Pharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of NXY-059, a novel neuroprotectant, on the pharmacokinetics of a single dose of digoxin in healthy subjects.
Gunilla Huledal, Dag Nilsson, Matts Kågedal, Ingalill Reinholdsson, Yi-Fang Cheng

Curr Med Res Opin· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active renal secretion of NXY-059, a novel neuroprotectant, is mediated via an organic acid transporter.
Yi-Fang Cheng, Stig Strid, Olof Borgå, Dag Nilsson, Johan Wemer

J Clin Pharmacol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: experiences from 13 phase I studies.
Lars Nyberg, Wiking Månsson, Bertil Abrahamsson, Janeric Seidegård, Olof Borgå

Eur J Pharm Sci· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
Magnus Korsgren, Morgan Andersson, Olof Borgå, Lars Larsson, Marie Aldén-Raboisson

Ann Allergy Asthma Immunol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NXY-059 does not significantly interact with furosemide in healthy volunteers.
Stig Strid, Dag Nilsson, Olof Borgå, Johan Wemer, Anders Grahnén

J Clin Pharmacol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole.
Carina Centerholt, Marianne Ekblom, Tomas Odergren, Olof Borgå, Gabriela Popescu

Eur J Clin Pharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
Stig Strid, Olof Borgå, Charlotte Edenius, Karl-Gustav Jostell, Tomas Odergren

Eur J Clin Pharmacol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis